Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AlloLife - Life After Allogeneic Hematopoietic Stem Cell Transplantation

NCT05087784 is registered in ClinicalTrials.gov with University Hospital, Essen as lead sponsor.

NCT NCT05087784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05087784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AlloLife - Life After Allogeneic Hematopoietic Stem Cell Transplantation
Lead sponsor
University Hospital, Essen
Phase
Not applicable
Overall status
Unknown status
Start date
March 31, 2024
Completion date
June 30, 2026
Enrollment
192 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

stem cell transplant complications, survivorship